TESARO Announces Immuno-Oncology Data Presentations at SITC 2018 Annual Meeting

World News: . []

WASHINGTON Nov 09 2018 GLOBE NEWSWIRE -- TESARO Inc LINK  TSRO an oncology-focused biopharmaceutical company today presented LINK  data from the Phase 1 AMBER trial of TSR-022 anti-TIM-3 antibody in combination with LINK  anti- PD-1 an...

More news and information about TESARO, Inc.

Published By:

Globe Newswire: 20:41 GMT Friday 9th November 2018

Published: .

Search for other references to "tesaro" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us